M. Coles

Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data

Ehrenstein, I. Bruce, Jane Worthington, 2018, RMD Open.

Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases.

Joyce B. Kang, S. Raychaudhuri, F. Powrie, 2022, Med.

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19

Calliope A. Dendrou, I. Pavord, G. Rodger, 2022, The Lancet Digital Health.

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Francisco Bonachela Capdevila, I. Bruce, Jane Worthington, 2022, Scientific Data.

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

V. Libri, P. Kearns, E. Sapey, 2021, The Lancet Respiratory Medicine.

From an Acorn to an Oak Tree

M. Coles, C. Hall, 2000 .